Abstract:Madam, The definition of health is far more complex than initially imagined. As per the World Health Organisation (WHO), the “health” is defined as complete physical, mental, and social well-being instead of simply the absence of any disease.1 In the era of modern healthcare, medications are undoubtedly important in ensuring well-being worldwide. Despite monumental advances within the medical industry, the rise of counterfeit medication has become an emerging threat. Counterfeit medications are known as products sold with the deception of providing therapeutic benefits but consist of little-to-no active ingredients, which may or may not be harmful.2 Traditionally, the regulation of drug distribution falls under the responsibility of the health authorities of the relevant region, such as the Drug Regulatory Authority of Pakistan (DRAP). Reports of an escalating influx of counterfeit medications into Pakistan have recently created pivotal concerns within the local communities.3,4 In Karachi, officials seized a large quantity of cefixime and aspirin suspension powders, which were found to be “fake and spurious”.3 The counterfeit medication was created by repackaging locally-manufactured powder into branded bottles, which were subsequently sold across the city. In another case affecting various cities in Pakistan, a factory was illegally manufacturing spurious medication, leading to a nationwide cautionary announcement to avoid the purchase of affected drugs, including the lifesaving meropenem, among various other cephalosporin drugs.4 The distribution of counterfeit medications can have drastic consequences for the population. Patients in critical conditions may suffer further harm due to defective treatment, as a result of the failure of substandard products.5 Moreover, counterfeit drugs manufactured with inappropriate doses or concentrations may lead to fatal adverse effects, such as respiratory paralysis or death.5 In order to address this pressing issue, the national authorities must take proactive measures to tackle the production and distribution of counterfeit medication: There is a need for frequent and strict raids integrated within each city of Pakistan, in which local pharmacies have their inventory tested for substandard or inappropriate substances. Secondly. The import of medications must also be strongly monitored, in order to prevent the arrival of counterfeit or unregistered medications from foreign regions. It is recommended that the authorities establish pharmaceutical support programs for those individuals who cannot afford proper medications and eventually resort to purchasing substandard medication.

Electrospinning formaldehyde-crosslinked zein solutions†

A review of existing and emerging digital technologies to combat the global trade in fake medicines

Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries

Unmasking Medical Frauds

Transanterior perforating substance approach to the thalamomesencephalic junction.

Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.

Regulation of actin synthesis in rat hepatocytes by cytoskeletal rearrangements.

Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health

Four decades of counterfeit research: A bibliometric analysis

Securing pharmaceutical supply chain using digital drug serialization

The rise of counterfeit medication: an emerging threat?

A systematic review of digital technology and innovation and its potential to address anti-corruption, transparency, and accountability in the pharmaceutical supply chain

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research

Inferring sources of substandard and falsified products in pharmaceutical supply chains

Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature

Information and Communication Technology in Combating Counterfeit Drugs

Pharmaceutical supply chain management: Ensuring quality and security in the distribution of medicines

Falsified and Substandard Drugs: Stopping the Pandemic

Assessment of Blockchain Technology as Remedy to Counterfeit Drugs Problem in Pharmaceutical Supply Chain and Implementation Approach

An exploratory assessment of the legislative framework for combating counterfeit medicines in South Africa

A Hybrid Framework of Blockchain and IoT Technology in the Pharmaceutical Industry: A Comprehensive Study